Humana (NYSE:HUM) Trading Up 8.6% – Here’s Why

Humana Inc. (NYSE:HUM)’s share price was up 8.6% during mid-day trading on Monday . The stock traded as high as $331.87 and last traded at $331.5560. Approximately 254,686 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 1,920,737 shares. The stock had previously closed at $305.42.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on HUM shares. Morgan Stanley increased their price target on shares of Humana from $146.00 to $217.00 and gave the stock an “underweight” rating in a research note on Friday, May 15th. Piper Sandler reiterated a “neutral” rating and issued a $254.00 price target (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Mizuho increased their price target on shares of Humana from $290.00 to $335.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 20th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research note on Tuesday, April 21st. Finally, Guggenheim raised their price objective on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $272.65.

Humana Stock Performance

The firm has a market capitalization of $38.49 billion, a P/E ratio of 34.29, a price-to-earnings-growth ratio of 2.38 and a beta of 0.76. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50 day simple moving average is $235.19 and its two-hundred day simple moving average is $229.58.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue was up 23.5% compared to the same quarter last year. During the same period last year, the business earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Institutional Trading of Humana

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after acquiring an additional 106,030 shares during the last quarter. Capital International Investors boosted its holdings in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after acquiring an additional 1,398,774 shares during the last quarter. State Street Corp boosted its holdings in shares of Humana by 1.8% during the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after acquiring an additional 97,211 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Humana by 28.9% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after acquiring an additional 1,008,514 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.